Sentinel lymph node biopsy (SLNB) has become the preferred method of surgical
pathological nodal staging of early breast cancer by the end of the nineties. As the most …

Controversies and inconsistencies regarding the pathological work-up of sentinel lymph
nodes (SNs) led the European Working Group for Breast Screening Pathology (EWGBSP) to …

Pathologic examination of the sentinel lymph nodes (SLNs) in patients with breast cancer
has been impacted by the publication of practicing changing trials over the last decade. With …

Sentinel lymph node biopsy (SLNB) was introduced 2 decades ago and thereafter validated
for routine surgical management of breast cancer, including cases treated with neoadjuvant …

Several controversial aspects of sentinel lymph node biopsy (SLNB) for patients with early-
stage, node-negative breast carcinoma have been dealt with and resolved in the past …

Sentinel lymph node biopsy (SLNB) has become the standard of care for early breast
cancer. Its use in breast cancer has been evaluated in several randomized controlled trials …

Sentinel lymph node (SLN) biopsy has been established as the standard of care for axillary
staging in patients with invasive breast carcinoma and clinically negative lymph nodes (cN …

During the recent years, based on the results of validation studies, the sentinel lymph node
biopsy has replaced routine axillary dissection as the new standard of care in early breast …

Despite the widespread use of sentinel lymph node biopsy (SLNBx) in the surgical
management of breast cancer patients, several areas remain controversial. The following …

Recent data indicates that the sentinel lymph node biopsy (SLNB) is a possible alternative to
axillary lymph node dissection (ALND) in early breast cancer patients, with minimal risk of …